coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Middleton PCN, Rochdale (LAD) · Health Inequalities Profile

    PCN U16428 · NHS Greater Manchester Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    45,196

    Registered population

    59.7% aged 18–64

    17.5%

    Aged 65+

    ICB 14.9% · England 17.9%

    46.0%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~19,032

    Core20 residents (est.)

    Resident basis; registered basis ~21,509 · see page 3

    6,843

    Hypertension register

    +3.87% in 3 yrs · England +5.60%

    517

    SMI register

    16.6% of Rochdale (LAD)'s

    1,241

    COPD register

    Reviews +0.76% in 3 yrs

    Forecast to 2030

    7,650

    Hypertension patients, 2030

    +807 on today

    74.9%

    QRISK ≥20% on statins, 2030

    +4.53pp over 3 yrs

    4.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    41.9 pp
    Core20 deprivation spans 41.9 pp across practices.

    Core20 share ranges from 31.2% at The Junction Surgery to 73.1% at Woodside Medical Centre (6,468 estimated patients), focusing need in specific lists.

    -12.3%
    Learning disability and dementia registers contracted.

    From 2023 to 2025, learning disability prevalence fell 12.3% (England +5.4%; 276 patients) and dementia fell 0.4% (England +6.0%), which may reflect coding gaps.

    85.0%
    Older-adult blood pressure and asthma reviews lead.

    BP control aged 80+ is 85.0% (England 81.2%) and asthma reviews reach 71.6% (England 65.7%), though about 880 asthma patients remain unreviewed.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Registered patients include 10,338 aged 0-17 and 7,889 aged 65+, potentially shaping dual demand

    Across 45,196 registered patients, 22.9% (10,338) are aged 0-17, compared with 23.5% in Rochdale, 21.8% in NHS Greater Manchester Integrated Care Board and 19.6% in England. Those aged 65+ account for 17.5% (7,889 patients), above Rochdale (14.7%) and the ICB (14.9%), but below England (17.9%). The 18-64 band comprises 59.7% (26,969 patients). Recorded Roma residents represent 0.1% and Gypsy or Irish Traveller 0.0%. Projected list growth to 2030 is 1.7% (Rochdale 1.4%, ICB 1.6%, England 2.3%), though observation periods and projection methods are unverified.

    Age profile

    0–1722.9%
    18–6459.7%
    65+17.5%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Rochdale (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Rochdale LA)2,3002,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)80.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.0%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Rochdale LA)1,0881,0219552024/25
    Falls deaths, all ages, per 100,000 (Rochdale LA)19.018.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 46.0% PCN-wide and spans 41.9 percentage points across practices

    Across Middleton PCN, 46.0% of registered patients live in Core20 areas (England 21.0%, ICB 40.7%, Rochdale 48.0%). Weighted practice share is 47.6%, making practice estimates indicative targeting aids rather than exact headcounts. Core20 share spans 41.9 pp, from 31.2% at The Junction Surgery to 73.1% at Woodside Medical Centre. Concentration is highest at Woodside Medical Centre (73.1%) and Windermere Surgery (68.5%), while volume peaks at Woodside Medical Centre (6,468 estimated patients) and Durnford Medical Centre (3,919). Outreach can balance high-concentration lists against high-volume caseloads across distinct practices.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Woodside73.1% · 6,468 patients
    Windermere68.5% · 1,979 patients
    Rochdale Road54.5% · 3,362 patients
    Durnford40.4% · 3,919 patients
    Peterloo34.5% · 3,108 patients
    Junction31.2% · 2,673 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    517

    SMI register

    1.14% recorded prevalence

    276

    Learning disability register

    0.61% recorded prevalence

    11

    Care homes, 358 beds

    In the PCN catchment

    9.7%

    Provide unpaid care

    Rochdale (LAD), Census 2021

    The PCN records 517 patients on the severe mental illness register (1.1%, against 1.0% in England) and 276 on the learning disability register (0.6%, matching England at 0.6%). The catchment includes 11 care homes with 358 beds, though bed capacity does not establish registered resident numbers.

    Severe mental illness: physical health checks

    SMI prevalence is 1.1% (England 1.0%). Annual blood pressure checks reached 84.1% (England 83.4%), though 2023 to 2025 progress fell 0.2 pp (England +4.4 pp); BMI checks reached 82.2% (England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,843

    Hypertension register

    +3.87%

    Register growth, 3 yrs

    Rochdale (LAD) +6.17% · England +5.60%

    +2.60pp

    BP control, under 80

    ≤140/90 · +4.21pp aged 80+

    +807

    More patients by 2030

    Forecast 7,650 (16.33%)

    Hypertension case-finding and control

    MIDDLETON PCN records 6,843 patients with hypertension (15.1% prevalence), compared with England (15.2%), NHS Greater Manchester Integrated Care Board (14.4%) and Rochdale (15.6%). Unadjusted prevalence against comparators yields a modelled gap range of +40 to +217 patients. From 2023 to 2025, register growth was +3.9% (England +5.6%; Rochdale +6.2%). Blood pressure monitoring reached 90.2% (England 90.0%), and BP control in patients aged 80+ reached 85.0% (England 81.2%; Rochdale 83.8%). Across practices, prevalence spans from 12.9% at Rochdale Road Medical Centre to 17.3% at Durnford Medical Centre. Slower register growth than borough comparators may reflect under-detection, which practice clinical audits could verify.

    Lipids and statins

    Patients with QRISK ≥ 20% treated with lipid lowering therapy reach 64.8% (England 63.6%; Rochdale 68.3%). Statin therapy reaches 75.1% for patients with diabetes aged 40+ without CVD (England 73.2%; Rochdale 76.6%). Trailing borough lipid coverage may reflect treatment gaps, which clinical audits could verify.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202688,308£2.00£1.94£1.86£176,616
    Cardiovascular (all), 2025113,500£3.40£3.15£3.33£385,900

    Lipid-regulating drugs in 2026 cost £2.00 per item across 88,308 items (£176,616 annual spend). The PCN spends £12,363 more than at England's unit cost (£1.86) and £5,298 more than at NHS Greater Manchester Integrated Care Board's unit cost (£1.94). Higher unit costs than England could reflect local formulary choices, which prescribing audits could review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +9.97%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −2.17%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.4% (England 6.6%), covering 3,108 patients, with 71.6% reviewed in the last 12 months (England 65.7%), leaving about 880 patients unreviewed. Asthma management items reached 2,177 per 1,000 aged 5-19 (England 1,488; Rochdale 1,888). COPD prevalence is 2.8% (England 1.9%, 1,241 patients) with 79.0% reviewed (England 76.4%). High paediatric prescribing may reflect underlying disease burden, which inhaler adherence audits could evaluate.

    Cancer register and children's immunisation

    Cancer prevalence is 3.9% (England 3.8%), covering 1,739 patients. In Q1 2025/26, 6-in-1 coverage at 24 months reached 94.9% (England 92.2%). At age 5, MMR dose 2 was 80.8% (England 82.8%), sitting below the 95.0% target by 14.2 pp, with an 8.3 pp difference from dose 1 (89.1%). The 4-in-1 booster reached 78.2% (England 80.9%), below the 95.0% target by 16.8 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.1%

    England 91.0%

    6-in-1 complete primary course at 24 months94.9%

    England 92.2%

    MMR dose 1 at 24 months86.9%

    England 88.3%

    MMR dose 2 at age 580.8%

    England 82.8%

    4-in-1 pre-school booster at age 578.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Across NHS Greater Manchester ICB in 2022, 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2 (England 55.3%), sitting 19.4 pp below the 75.0% national ambition by 2028 (about 2,270 extra early-stage cases needed annually). Known-stage coverage was 70.8% (11,679 of 16,492; England 67.0%). Early-stage diagnosis reached 40.4% in lung and 46.3% in bowel, but 82.5% in breast. System data reflects wider pathway presentation, not PCN delivery. Lower early detection in bowel compared to England and the distance to the 75.0% ambition across cancer types highlight an opportunity to review referral and safety-netting pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Northern Care Alliance NHS Foundation Trust reached 78.6% on the 62-day standard (6.4 pp below the 85.0% standard), above Manchester University NHS Foundation Trust (72.8%), Tameside and Glossop Integrated Care NHS Foundation Trust (76.8%), NHS Greater Manchester Integrated Care Board (75.7%) and England (71.2%). On the 28-day faster diagnosis standard, Northern Care Alliance achieved 75.2%, meeting the 75.0% standard but behind the ICB (79.5%) and England (79.3%). Diagnostic 6+ week waits were 5.1% for MRI and 4.1% for CT (England 21.4% and 9.9%). Provider data reflects acute pathways, not PCN delivery.

    Pathways within standard (%)Northern Care AllianceManchesterTameside and Glossop Integrated CareGreater Manchester ICBEngland
    28-day faster diagnosis (75%)75.2080.0682.4879.5379.32
    31-day treatment (96%)94.5492.5496.2596.4992.50
    62-day referral to treatment (85%)78.6572.8576.7775.7371.16
    Diagnostic waits over 6 weeks (%)Northern Care AllianceManchesterTameside and Glossop Integrated CareEngland
    MRI5.0911.680.0021.40
    CT4.1014.660.189.92
    Echocardiography31.484.910.0028.48
    Colonoscopy40.044.511.5130.83
    Gastroscopy36.4829.355.4529.02
    All 15 DM01 tests15.718.980.8023.14
    Community services activityRochdale residentsGreater Manchester ICB
    Care contacts60,250573,310
    Referrals9,45594,470
    Patients with a contact19,345183,535

    Community services (residents of Rochdale), Jun 2026 (provisional). In Jun 2026 (provisional), adults aged 65+ accounted for 40.9% of all community service contacts among Rochdale borough residents (24,650 of 60,250 contacts; borough data, not PCN level). Older-age community contacts indicate borough-level demand for intermediate care coordination.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, QOF clinical-domain achievement was 100.0% at Peterloo Medical Centre (England 97.1%) and 90.2% at Windermere Surgery. QOF vaccination and immunisation-domain achievement spanned 28.3 pp, ranging from 15.6% at Rochdale Road Medical Centre to 43.9% at Woodside Medical Centre (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Rochdale Road9654.567.9%73.1%86.7%
    Windermere Surgery9368.579.0%63.8%85.7%
    Durnford10740.463.4%77.4%83.7%
    Junction12331.267.5%70.7%82.4%
    Peterloo10634.547.4%69.1%75.4%
    Woodside11873.131.7%69.9%71.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNRochdale (LAD)AssetPCNRochdale (LAD)
    Care homes (catchment)11 (358 beds)n/aSchools (catchment)45n/a
    Children's centres417Places of worship24116
    Libraries212Primary schools (LA maintained)1138
    Primary academies326Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension case-finding and lipid review

    Hypertension prevalence is 15.1% (6,843 patients; Rochdale 15.6%, England 15.2%), giving an unadjusted gap of +40 to +217 patients. QRISK ≥ 20% lipid therapy is 64.8% (Rochdale 68.3%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Learning disability, dementia and SMI audit

    From 2023 to 2025, learning disability prevalence fell 12.3% (276 patients, 0.6%; gap -10 to +21) and dementia fell 0.4% (334 patients, 0.7%; gap +19 to +20). SMI BP checks fell 0.2 pp. Moderate effort to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Option 3

    Pre-school booster and asthma review recall

    In Q1 2025/26, age-5 MMR2 is 80.8% (below 95.0% by 14.2 pp) and 4-in-1 is 78.2% (below by 16.8 pp). Asthma reviews reach 71.6%, leaving 882 of 3,108 patients unreviewed. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Dual pathway capacity review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 outreach model (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre school immunisation recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    System early diagnosis alignment (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Option 1 · Hypertension case-finding and lipid review (p12)Hypertension register · Hypertension: QOF prevalence · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Learning disability, dementia and SMI audit (p12)Learning disability register · Learning disability: QOF prevalence · Dementia register75% annual health checks (Network Contract DES) · Oliver McGowan · 66.7% diagnosis ambition · 95% care plan 2027PCN & Practice
    Option 3 · Pre-school booster and asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15